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A CURRICULUM CONTENT CHANGE INCREASED MEDICAL STUDENTS' 
KNOWLEDGE AND COMFORT WITH TRANSGENDER MEDICINE  
SVEN ERIKSSON 
ABSTRACT 
Introduction: Transgender individuals experience distress due to the persistent 
feeling that their gender identity is incongruent with their assigned sex. This 
distress is associated with depression, a high suicide rate, and increased 
mortality. The best solution for transgender patients is cross-sex hormone 
therapy, a treatment that changes the physical sex of the patient to be more 
congruent with their gender identity. This treatment has been proven to reduce 
depression and suicide rates, as well as increase overall quality of life. 
Unfortunately transgender patients face unacceptable barriers to accessing this 
treatment, due in most part to the lack of willing and knowledgeable transgender 
care providers. Many physicians share the misconceptions that gender identity is 
malleable, making transgender identity a psychiatric problem, and that cross-sex 
hormone therapy may not be effective and carries too great a risk. However, the 
literature supports the notion that gender identity is a rigid biological 
phenomenon and that cross-sex hormone therapy is safe and effective. Studies 
reporting failed attempts to assign female sex to XY patients with disorders of 
sexual development provide evidence that gender identity is not malleable. Other 
studies reporting elevated gender identity disorder rates in XX individuals with 
excess prenatal androgen suggest that gender identity is a biological 
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phenomenon influenced by hormones during prenatal development. 
Neuroanatomical studies of transgender cadavers report that some sexually 
dimorphic areas of the transgender brain are more similar to the opposite sex 
than the natal sex, suggesting that gender identity is a rigid biological 
phenomenon originating in the structure of the brain. A review of the side effects 
and risks associated with cross-sex hormone therapy concluded that treatment is 
safe provided the physician is familiar with the recommended treatment and 
monitoring regimens. The lack of transgender care providers is perpetuated by 
the fact that transgender medicine is not a standard part of the medical school 
curriculum. Few physicians, therefore, have experience or training in transgender 
medicine, which is why, to combat this problem, this study has focused on the 
medical school education system. Previous studies have demonstrated that the 
addition of transgender medicine to the medical school curriculum increases 
student comfort and willingness to provide transgender care. Building upon these 
findings the present study aims to demonstrate that the addition of transgender 
medicine to the medical school curriculum is an effective means to increase 
knowledge and change attitudes towards transgender medicine. 
Methods: A single lecture on gender identity and transgender medicine was 
added to the mandatory first-year biochemistry course and the mandatory 
second-year pathophysiology course at Boston University School of Medicine. An 
audience response survey was conducted immediately before and after the first-
year lecture to assess the change in students opinions regarding of the etiology 
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of gender identity. An elective online survey consisting of two exam style 
questions was also sent to the first-year students prior to exposure to the 
curricular content. The same questions were also added to the first-year 
biochemistry and second-year pathophysiology exams following exposure to the 
content. The exam-style questions were designed to assess student knowledge 
of the rigidity of gender identity and transgender medicine. 
Results: Following exposure to the curricular content there was an increase in 
the number of students who believe that the origin of gender identity is in the 
neuroanatomical structure of the brain (p<0.001). The relative number of correct 
responses to the exam-style questions significantly improved between the online 
survey and the first-year exam (p<0.001). On one of the exam questions there 
was no significant difference between the relative number of correct responses 
given first-year students the second-year students. On the other exam question 
the second-year students performed significantly worse (p<0.001). 
Conclusion: Here we demonstrate that the addition of transgender medicine to a 
medical school curriculum can increase students’ knowledge and change their 
attitudes towards transgender medicine. Following the curricular content students 
were convinced that gender identity is a rigid biological phenomenon and that 
cross-sex hormone therapy is a medically justified treatment. These findings 
suggest that a simple curricular content change is an effective means of training 
knowledgeable physicians who are willing to provide transgender care. 
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INTRODUCTION 
 
 The term “transgender” is used to describe someone who has the 
persistent feeling that his or her gender identity is incongruent with his or her 
assigned biological sex (Cole, O’Boyle, Emory & Meyer, 1997). While being 
transgender is not considered a mental disorder in its own right, if the gender-sex 
incongruence causes distress to the point where it interferes with social or 
occupational functions, a diagnosis of gender dysphoria may be made (American 
Psychiatric Association, 2013). Transgender individuals are also highly 
susceptible to other mental health concerns (e.g. anxiety and mood disorders), 
often stemming from societal discrimination, prejudice, gender related 
harassment or violence, and rejection and alienation from family and friends 
(Lombardi, Wilchins, Priesing, & Malouf, 2002; Williamson, 2010; Hoffman, 
2014). There are as many as 700,000 transgender individuals living in the United 
States (Gates, 2011), an estimated 2/3rds of whom suffer from depression and 
1/3rd of whom will attempt suicide during their lifetime (Clements-Nolle, Marx, & 
Katz, 2006). Fortunately for these individuals, an effective therapy has been 
developed for their mental health concerns and general wellbeing, “transitioning” 
(Murad, Elamin, Garcia, Mullan, Murad, Erin, & Montori, 2010). Transitioning is 
the process of altering one’s social, legal and physical characteristics to make 
one’s external gender expression match one’s internal gender identity (Hembree, 
Cohen-Kettenis, Delemarr-van de Waal, Gooren, Meyer, Spack, Tangpricha, & 
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Montori, 2009). Healthcare professionals assist with the physical aspect of the 
transitioning process through the means of cross-sex hormone therapy and 
sometimes genital sex reassignment surgery (Hembree et al., 2009). The 
greatest barrier to obtaining this treatment is a lack of access to care due to the 
fact that few physicians are both willing and knowledgeable enough to provide 
safe quality care (Safer & Tangpricha, 2008). Furthermore, many physicians 
share the misconception that gender identity is a malleable social construct and 
can therefore be reversed through cognitive-behavioral therapy and other 
psychiatric interventions (Safer & Tangpricha, 2008). This misconception may be 
rooted in the fact that research into the etiology of transgender identity has not 
identified any genetic, hormonal, gonadal, or genital causes, which only leaves 
psychological and/or neurological causes (Zhou, Hofman, Gooren, & Swaab, 
1995). Additionally, physicians question the legitimacy of hormonal therapy 
specifically its effectiveness and safety (Safer & Tangpricha, 2008). Despite 
these objections to cross-sex hormonal therapy a review of the literature provides 
compelling evidence that gender identity is a rigid biological phenomenon and 
that cross-sex hormonal therapy is safe and beneficial for transgender patients. 
 While no set of genes or prenatal events have been identified as specific 
causes of transgender identity or as specific predispositions towards developing 
a transgender identity, studies of the gender identities of individuals with 
disorders of sexual development provide strong evidence that gender identity is 
at least partially the result of nature as apposed to nurture. One particular study 
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followed a cohort of 14 XY individuals who were born with cloacle extrophy, a 
congenital abnormality affecting the pelvis and specifically resulting in severe 
genital inadequacy (Reiner & Gearhart, 2004). Based on the concept of neonatal 
sexual neutrality, the idea that gender is a blank slate for both genetic boys and 
girls at birth and is only dictated by post-natal hormones and experiences, and 
the limitations in penile reconstructive surgery these XY individuals were legally, 
socially and surgically assigned female sex within two weeks of birth (Reiner & 
Gearhart, 2004). This idea that a person who appears physically female and is 
raised as such, with no knowledge of their genetics or circumstances of birth will 
naturally assume a female gender identity was the driving force behind what was 
the recommended treatment for patients with disorders of sexual development 
(Reiner & Gearhart, 2004). However, during follow up visits 4 of the 14 patients 
independently declared their gender to be male, despite having been told by their 
parents that they were female, and another 4 patients openly declared their 
gender to be male after learning of their XY genetics and their surgery (Reiner & 
Gearhart, 2004). One patient left the study after finding out their XY genetics, and 
the remaining 5 continued to live as females with no knowledge of their XY 
genetics (Reiner & Gearhart, 2004). Interestingly, when the psychosocial 
wellbeing of the remaining 13 participants was evaluated, the 8 participants living 
as males were better socialized and more comfortable with their own sexuality, 
giving some credence to the idea of not altering gender identity (Reiner & 
Gearhart, 2004). The fact that XY individuals, who appear outwardly female and 
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were raised as females, spontaneously declared themselves male suggests that 
there is some chromosomal involvement in gender, which is evidence that 
gender identity is a biological phenomenon, not a social construct. While the 
rejection of the given gender identity in the Reiner & Gearhart study provides the 
most direct evidence that gender identity is not malleable, additional studies shed 
doubt on our ability to externally influence gender identity. A study surveying a 
group of 72 XY men and women who were born with a DSD on their satisfaction 
with their gender and their surgical outcome found that while women were on 
average happier with their surgical outcome over half of these women had 
experienced gender confusion (Meyer-Bahlburg, Migeon, Berkovitz, Gearhart, 
Dolezal, & Wisniewski, 2004). These results support the notion that, while you 
can make someone appear outwardly female, their gender identity will not 
necessarily follow suit.  
 The biological nature of the etiology of gender identity is not just apparent 
in XY individuals. A study involving a number of XX individuals with congenital 
adrenal hyperplasia (CAH) also supports the notion that gender identity is not 
simply a social construct (Slijper & Drop, 1998). CAH is a condition affecting an 
enzyme involved in the production of cortisone in the adrenal glands, which 
results in the over-production of adrenal androgen, leading to virilization during 
the development of the female genitalia (Slijper & Drop, 1998). Additionally, the 
prenatal and postnatal effects of the increased androgen in individuals with CAH 
have been noted to result in what is described as “more boyish conduct” than the 
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girls in the general population (Slijper & Drop, 1998). Slijper & Drop examined 18 
XX individuals with CAH and an assigned female sex. Of these 18, two XX 
individuals met the criteria for a diagnosis of gender identity disorder (GID) 
according to the DSM-IV (Slijper & Drop, 1998). While 11% may be a low 
number, it is significantly higher than the incidence of GID in the general 
population, suggesting that the prenatal exposure to extra androgen does have 
an effect on gender identity. However, because 11% is a minority, it is clear that 
CAH does not cause transgender identity, but rather predisposes the individual to 
developing a transgender identity, suggesting that gender identity in general is 
the product of the interplay between nature and nurture. Slijper & Drop also 
looked at 14 XY individuals with complete androgen insensitivity syndrome 
(CAIS). CAIS is a congenital condition that results in the development of female 
external genitalia and testes in the abdominal or inguinal body cavities 
(Deshpande, Chaudhari, & Sharma, 2010). CAIS is caused by a mutation in the 
gene that codes for the cellular androgen receptor, resulting in individuals with 
who are completely unaffected by androgen (Deshpande et al., 2010). Individuals 
are still sensitive to feminizing hormones, however, and often develop female 
secondary sex characteristics (Deshpande et al., 2010). Additionally the mutation 
in the androgen receptor does not affect anti-Mullerian factor; as a result, 
individuals with CAIS do not develop a uterus or fallopian tubes (Deshpande et 
al., 2010). Because of the physical outward appearance of CAIS individuals all 
18 participants in the Slijper & Drop study were assigned female sex at birth 
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(Slijper & Drop, 1998). These participants were tested for GID, but none of them 
qualified for a diagnosis (Slijper & Drop, 1998). The fact that androgen sensitive 
XY individuals with cloacal extrophy rejected the female-sex assignment, but XY 
individuals with CAIS did not, suggests that hormones are a key influence in the 
development of gender. However, the absence of reported gender identity 
changes in patients who undergo hormone replacement therapy is evidence that 
postnatal hormones do not have a significant effect on gender identity. Therefore, 
gender identity is established during prenatal development, and remains rigid as 
development continues.  
 While studies of gender identity in patients with disorders of sexual 
development give us insight into the biological nature of gender identity in 
general, studies of the brains of transgender cadavers provide the most direct 
evidence that a transgender identity is also a biological phenomenon.  Zhou et al. 
looked at the bed nucleus of the stria terminalis (BST) of the hypothalamus in 
heterosexual men, homosexual men, heterosexual women, and male-to-female 
transgender individuals (MTF). In rodents the BST plays a key role in determining 
male or female sexual behavior and contains a large number of estrogen and 
androgen receptors (Zhou et al., 1995). Additionally the size of the BST is 
sexually dimorphic in rodents (Zhou et al., 1995). While there is no way to 
determine the gender identity of a rodent, it is likely, given the BST’s dimorphic 
structure and functions, that the BST has some role in gender identity (Zhou et 
al., 1995). Using a non-specific vasoactive intestinal peptide (VIP) stain Zhou et 
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al. measured the size of the BST in cadavers. The results, which are illustrated in 
Figure 1 and Figure 2, show that men have a significantly larger BST than 
women; that there is no significant size difference between heterosexual men 
and homosexual men; and, most relevantly, that MTFs have a significantly 
smaller BST than both heterosexual and homosexual men and do not 
significantly differ from heterosexual women (Zhou et al., 1995). In other words 
the transgender woman’s brain is more similar to a female brain than a male 
brain. While the specific cause of this difference has not been identified a number 
of controls were included in the study to assess the effects of hormones on BST 
size. Three of the MTFs in the study had been off estrogen for between 3 and 15 
months prior to death, two of the MTFs had not taken anti-androgen for 2 and 10 
years prior to death, and one MTF had not had an orchiectomy, yet none of these 
MTFs had a significantly different BST size when compared to the other MTFs in 
the study, suggesting that neither cross-sex hormone therapy nor orchiectomy 
were significant influences on BST size (Zhou et al., 1995). Additionally a man 
with an estrogen secreting tumor, a natural model for estrogen supplements, two 
men with orchiectomies due to cancer, natural models for anti-androgen 
medication, and two post-menopausal women, natural models for cessation of 
estrogen supplement, all had BST sizes similar to that of their respective sexes, 
suggesting that changes in hormone levels have no effect on the size of the BST 
(Zhou et al., 1995). The fact that hormones appear to have no effect on the 
apparent female structure of the BST in MTFs and that no specific genes have 
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been associated with transgender suggests that this difference from the typical 
XY brain is the result of prenatal neural development, and therefore would not 
respond to psychiatric therapy. These findings suggest that transgender identity 
is hard-wired into the structure of the brain, which is why transgender and gender 
identity in general are rigid biological phenomena.  
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Figure 1: The Bed Nucleus of the Stria Terminalis of Four Individuals. A 
non-specific VIP stained cross section of BST in a heterosexual man (a), a 
heterosexual woman (b), a homosexual man (c), and a MTF (d) is shown. The 
BST size difference between heterosexual and homosexual men and cisgender 
and transgender women is illustrated here. The crossbar in the lower right 
represents 0.5 mm. (Figure take from Zhou et al., 1995) 
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Figure 2: Relative Sizes of the Bed Nucleus of the Stria Terminalis in 
Heterosexual and Homosexual Men, Women, and MTFs. This is a graphical 
representation of the mean size of the BST in four groups: ‘M’ represents the 
heterosexual male group, ‘HM’ represents the homosexual male group, ‘F’ 
represents the heterosexual female group, and ‘TM’ represents the MTF group. 
There is no significant difference in size between the M and HM groups or the F 
and TM groups. There is a significant difference between the female group and 
both male groups. There is also a significant difference between the MTF group 
and both male groups. (Figure taken from Zhou et al., 1995) 
 
 
Once transgender identity is recognized as a rigid biological phenomenon 
cross-sex hormone therapy remains the recommended treatment paradigm, 
however many physicians question its efficacy and safety (Safer & Tangpricha, 
2008).  With regards to the efficacy of cross-sex hormone therapy, a review of 
the literature between 1966 to early 2008 comprising 1093 MTFs and 801 FTMs 
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who had received cross-sex hormone therapy found that 80% of individuals 
reported improvements with gender dysphoria (Murad et al., 2010). Additionally 
78% of individuals reported improvement with other mental health concerns, and 
suicide rates decreased significantly, yet still remaining higher than the general 
population (Murad et al., 2010). Finally 80% of people reported more stable 
relationships, better adjustment, more overall happiness, and an improved quality 
of life following cross-sex hormone therapy (Murad et al., 2010).  
The safety of cross-sex hormone therapy is affirmed by the literature 
provided that care is obtained from a physician trained in the supervision of the 
treatment and the risks involved (Weinand & Safer, 2015). As with any treatment 
there are some risks of side effects, which must be monitored, but the risks are 
relatively minor. There has been some association of cross-sex hormone therapy 
with venous thrombosis in MTF patients (Weinand & Safer, 2015). However, the 
reported incidence of thrombosis in MTFs is only between 1-8%, and that data is 
confounded by patients who were treated with the thrombogenic estrogen 
supplement ethinyl oestadiol, which is no longer used in the current treatment 
regimen (Weinand & Safer, 2015). One study has even reported a decrease in 
thromboembolism and other cardiovascular issues with the use of transdermal 
17ß estradiol, despite the fact that several of the patients in the study had 
hypercoaguable gene deficiencies, predisposing them to thromoembolism (Ott, 
Kaufmann, Bentz, Huber, & Tempfer, 2010). Regardless of whether or not there 
is an increased risk of embolism, the current treatment regimen recommends 
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minimizing other risk factors and monitoring for thromboembolism (Hembree et 
al., 2009). Another potential side effect listed in the treatment guidelines is an 
increased risk of cancer, a concern that the literature does not support (Hembree 
et al., 2009; Weinand & Safer, 2015). In terms of breast cancer, there does not 
appear to be any additional risk in trans-men or trans-women compared to men 
and women, respectively (Wierckx, Mueller, Weyers, van Caenegem, Roef, 
Heylens, & T’sjoen, 2012). For FTMs testosterone appears to cause atrophy of 
the endometrial tissue and the cervical epithelium, reducing risk of cancer 
(Weinand & Safer, 2015) Additionally, one study reported no increase in genes 
related to endometrial proliferation or malignancy among FTMs (Gardner & 
Safer, 2013). There are reports of prostate cancer among MTFs amounting to an 
incidence of 0.04%, compared to the national incidence of 15% among all males 
(Weinand & Safer, 2015; National Cancer Institute, 2011). Although there is no 
additional risk of cancer in transgender patients an important consideration for a 
physician treating a transgender patient, whether they are providing cross-sex 
hormone therapy or not, is monitoring for cancers associated with the natal sex, 
i.e. cervical and prostate (Weinand & Safer, 2015). Although transgender 
individuals as a group have an increased mortality of 51%, this elevated mortality 
is caused by the increased suicide, AIDS, and substance abuse rates, not cross-
sex hormone therapy, which does not increase mortality (Asscheman, Giltay, 
Megens, Ronde, Trotsenburg, & Gooren, 2011; Weinand & Safer, 2015). There 
does appear to be some decrease in insulin sensitivity and elevated fasting 
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glucose, increasing the risk of type II diabetes (Weinand & Safer, 2015). 
However, the treatment regimen recommends monitoring blood glucose levels 
and, if there are additional diabetic predispositions in the patient, discussing the 
risks and benefits of treatment (Hembree et al., 2009). Overall cross-sex 
hormone therapy improves transgender patients’ health, wellbeing, and quality of 
life with minor risks, which can be ameliorated by following the recommended 
monitoring guidelines. 
Cross-sex hormone therapy is straightforward, clearly beneficial to the 
patient, and safe when supervised by a trained physician. Unfortunately, the 
biggest barrier to obtaining this therapy is access to a trained physician (Safer & 
Pearce, 2013). Due to the general lack of knowledgeable providers some 
desperate transgender patients even seek alternative means of obtaining 
treatment, like the Internet or unknowledgeable healthcare providers, which may 
not be able to provide safe quality care (Safer & Tangpricha, 2008). These 
disparities are perpetuated by the fact that few medical schools adequately cover 
transgender medicine in their curricula (Obedin-Maliver, Goldsmith, Stewart, 
White, Tran, Brenman, Wells, Fetterman, Garcia, & Lunn, 2011). It is because 
the apparent source of this disparity is lack of experience and education on the 
subject that research has been focused on developing ways to train 
knowledgeable physicians who are willing to provide transgender care through 
changes to the medical school curriculum. In 2013 Safer & Pearce published a 
study that tested the effects of such a change by adding transgender medicine 
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content to the endocrinology unit of the mandatory second-year pathophysiology 
course at Boston University School of Medicine. The curricular content focused 
on the evidence supporting gender identity as a rigid biological phenomenon, the 
cross-sex hormone therapy treatment regimens, and the monitoring regimens 
(Safer & Pearce, 2013). Prior to exposure to the content all of the medical 
students at the university were invited to take an online survey assessing their 
discomfort providing hormones to a hypogonadal male, a hypogonadal female, a 
MTF and a FTM (Safer & Pearce, 2013). Additionally the students were asked if 
they thought transgender medicine was an appropriate topic for conventional 
medicine and if they would turn away a transgender patient (Safer & Pearce, 
2013). The survey was sent out again following the second-year’s endocrinology 
unit, and the second year’s answers were compared to the responses given by 
rest of the medical students at the university (Safer & Pearce, 2013). The results, 
which are shown in Figure 3, showed that following exposure to the curricular 
content anticipated discomfort with treating a MTF decreased 63% and 
anticipated discomfort with treating a FTM decreased 67% (Safer & Pearce, 
2013). Additionally the relative number of students who reported that transgender 
medicine was inappropriate for conventional medicine dropped to 0 and the 
relative number of students who reported that they would refuse to treat a 
transgender patient also decreased significantly (Safer & Pearce, 2013). These 
results demonstrate that a change to curricular content is capable of altering 
medical professionals willingness to treat transgender patients, but do not 
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sufficiently demonstrate that students changed their views regarding gender 
identity or increased their knowledge of transgender medicine following the 
additional curricular content. 
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Figure 3. Anticipated Discomfort With Providing Transgender Care. Figure 
3A shows a 67% decrease in discomfort treating a FTM patient following 
exposure to the curricular content. Figure 3B shows a 63% decrease in 
discomfort treating a MTF patient. (Figure taken from Safer & Pearce, 2013) 
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Building upon Safer & Pearce’s results demonstrating that the addition of 
transgender medicine content focusing on the biological evidence for a rigid 
gender identity and the etiology of transgender identity to the medical school 
curriculum increased student comfort and willingness to treat transgender 
patients, we aim to demonstrate that such a curricular content change will both 
increase knowledge and change attitudes towards transgender medicine.
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METHODS  
 
 Curriculum content was added to the sex-steroid unit of the mandatory 
first-year biochemistry course and to the endocrinology unit of the mandatory 
second-year pathophysiology course at the Boston University School of 
Medicine. The first-year content consisted of a single lecture presenting the 
evidence for a rigid biological gender identity. The second-year content consisted 
of a single lecture reviewing the rigidity of gender identity, and covering the 
treatment regimens and monitoring requirements for cross-sex hormone therapy. 
The cohort of second-year students had received the first-year content during the 
previous year. The study consisted of two surveys: an audience response 
question and two exam-style questions. 
 
Audience Response Survey 
Immediately before and after the first-year lecture students were asked 
what they thought was behind the etiology of gender identity while presented with 
the slide shown in Figure 4. Each response choice on the slide was explained to 
the students before they answered. Responses were recorded using a digital 
clicker system with anonymous clicker identification numbers, allowing the 
matching of individuals’ answers before and after the lecture. A Pearson Chi-
Square test was used to analyze the overall answer choice frequencies of the 
pre-lecture and post-lecture responses. Additionally, McNemar’s Test was used 
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to analyze the matched pre-lecture and post-lecture responses for each answer 
choice. All statistical analysis was conducted with SPSS software.  
 
Figure 4. Audience Response Slide. Students were asked what they thought 
determined gender identity while presented with this slide. Each response was 
described to the class in the following ways: answer choice ‘1. Environment’ 
means that gender identity is the result of postnatal experiences and 
surroundings, ‘2. Social Construct’ means that gender is a learned set of 
behaviors arbitrarily established by societal conventions, ‘3. Anatomy’ means that 
gender is determined by primary sexual characteristics, ‘4. Hypothalamus’ means 
that the origin of gender identity is in the structure of the brain, ‘5. Chromosomes’ 
means that gender is determined by genetics, and ‘6. Hormones’ means that 
gender is the result of sex-hormone levels. Answer choice ‘4. Hypothalamus’ was 
the response indicated by the evidence presented during the lecture. 
 
 
1.  Environmental.
2.  Social.Construct.
3.  Anatomy.
4.  Hypothalamus.
5.  Chromosomes.
6.  Hormones.
Potential factors 
determining gender identity: 
Background 
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Exam-Style Survey 
Prior to the first-year lecture an elective anonymous online survey was 
sent to the students using the qualtrics service. The online survey consisted of 
two exam-style questions, which are described in Figure 5 and Figure 6, aimed at 
assessing knowledge of the etiology and the rigidity of gender identity. The online 
survey questions were then added to the first-year biochemistry exam given 
following the sex-steroid unit. The online survey questions were also 
incorporated in the second-year pathophysiology exam given following the 
endocrinology unit. The professors scored individual exams and only the overall 
performance on the two questions was collected for research purposes to protect 
the anonymity of students. Answer choice frequencies from the online survey and 
both exams were analyzed using Pearson’s Chi Square tests. All statistical 
analysis was conducted using SPSS software. 
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The first exam-style question was designed to assess how effective the 
curricular content was at imparting information regarding the etiology of 
gender identity. Specifically, this question required students to understand 
the evidence supporting the biological nature of transgender identity. The 
following is a description of what each answer choice suggested: 
A.  Transgender identity is associated with childhood 
psychological trauma. 
B.  Transgender identity is associated with an underlying 
hormone condition. 
C.  Transgender identity is associated with 
neuroanatomical microstructure that is more similar to 
the opposite sex. 
D.  Gender identity is a social construct. 
E.  Gender identity is tied to sexuality. 
Figure 5. Description of the First Exam Style Question. This is a description 
of the goals, prompts, and answer choices for one of the exam-style questions 
that was presented on the online survey, the biochemistry exam, and the 
pathophysiology exam. For the purpose of reporting, this question shall be 
referred to as the ‘the first exam question’; however, this question did not 
necessarily appear before the second exam question on the survey or exams. 
The correct answer is highlighted in bold here, but was not so on the survey or 
the exams. 
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The second exam-style question assessed students’ knowledge of gender 
identity, transgender identity, and cross-sex hormone therapy. Additionally 
it assessed whether or not students viewed cross-sex hormone therapy as 
a valid treatment. In this question students were presented with a 
transgender individual with additional mental health concerns and asked 
to select a treatment. The following is a description of what each answer 
choice suggested: 
A.  Transgender identity is the result of psychological stress and 
should be treated through psychiatric intervention. 
B.  Transgender identity is a set of maladaptive behaviors and 
should be treating through psychiatric intervention. 
C.  Only the additional mental health concerns should be 
treated. 
D.  Transgender identity is caused by an underlying hormonal 
imbalance that can be corrected. 
E.  Cross-sex hormone therapy is an appropriate treatment 
for transgender patients. 
Figure 6. Description of the Second Exam Style Question. This is a 
description of the goals, prompts, and answer choices for one of the exam-style 
questions that was presented on the online survey, the biochemistry exam, and 
the pathophysiology exam. For the purpose of reporting, this question shall be 
referred to as the ‘the second exam question’; however, this question did not 
necessarily appear after the first exam question on the survey or exams. The 
correct answer is highlighted in bold here, but was not so on the survey or the 
exams. 
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RESULTS 
 
 
 A total of 43 first-year students responded to the audience response 
survey. Of this sample 39 students answered both the pre-lecture and post-
lecture question. Two students only answered the question before the lecture 
and two students only answered the question after the lecture. There were 
therefore 41 students who answered the pre-lecture question and 41 students 
who answered the post-lecture question. 
 Prior to exposure to the curricular content 46% (n=41) of students believed 
that varying hormone levels in the body is what determines gender. A chi-square 
test determined that this response was chosen by a significant number of 
students, X2 (5, N=41) = 27.93, p<0.001. Following the first-year lecture 80% of 
students selected the response ‘Hypothalamus’, reflecting that the origin of 
gender identity is in the structure of the brain. A chi-square test determined that 
this response was chosen by a significant number of students, X2 (5, N=41) = 
123.9, p<0.001. In order to determine if the students responses after exposure to 
the curricular content were significantly different from their original responses a 
chi square test was performed, which showed that the difference was significant, 
X2 (5, N=82) = 36.69, p<0.001. Figure 7 illustrates the relative frequency with 
which the first-year students chose each response option before and after the 
lecture. Table 1 summarizes the individually matched responses that students 
gave pre-lecture and post-lecture. McNemar’s test was performed on each of the 
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response options to determine if a significant number of students changed their 
answer to or from a given response. The results of this test found that following 
exposure to the curricular content a significant number of students changed their 
answer from ‘Hormones’, X2 (1, N=39) = 5.50, p=0.019, and that a significant 
number of students changed their answer to ‘Hypothalamus’, X2 (1, N=39) = 
27.04, p<0.001.  
 
 
 
Figure 7. Responses to the Audience Response Question. These are the 
relative frequencies with which each response to the audience response 
question, which is shown in Figure 4, was selected immediately prior to the first-
year lecture (N=41) and immediately following the first-year lecture (N=41). 
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Table 1. Summary of Pre-Lecture and Post-Lecture Audience Response 
Data. These are the matched responses to the audience response question, 
which is shown in Figure 4. The rows represent individual students responses 
before the lecture and the columns represent matched responses from those 
students after the lecture. Empty cells represent zero respondents. A significant 
number of students changed their answer from hormones (p=0.019) and to 
hypothalamus (p<0.001) following the lecture. 
P
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Post-Lecture Response 
 
Environment 
Social 
Construct 
Anatomy Hypothalamus Chromosomes Hormones 
No 
Answer 
Environment 6 
  
1 
 
1 1 
Social 
Construct    
3 
 
3 
 
Anatomy 
   
1 
 
1 
 
Hypothalamus 
   
6 
   
Chromosomes 
   
4 1 
  
Hormones 
 
1 
 
16 
 
1 1 
No Answer 
   
2 
   
 
 A total of 56 first-year students responded the online survey prior to 
exposure to the curricular content. A total of 121 first-year students took the 
exam following the sex-steroid unit of the biochemistry course. A total of 189 
students took the exam following the endocrinology unit of the pathophysiology 
course. The pathophysiology course was made up of approximately 80% 
second-year medical students and 20% physician assistant students. Because 
the online survey and exam were anonymous it was not possible to determine 
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how individual students responded to the exam-style questions before and after 
the lecture. However, the exam was mandatory and therefore all of the 
respondents to the online survey should have taken the exam. 
 For the purposes of reporting results the exam-style questions shall be 
referred to as the ‘first exam question’ and the ‘second exam question’ in 
reference to Figure 5 and Figure 6, respectively. Prior to exposure to the 
curricular content 62.50% (n=56) of online survey respondents correctly 
answered the first exam question. A chi-squared test determined that this 
percentage was a significant, X2 (1, N=56) = 64.54, p<0.001. During the first-year 
biochemistry exam 92.56% (n=121) of students chose the correct response to 
the first exam question, which was also significant as determined by a chi square 
test, X2 (1, N=121) = 398.2, p<0.001. A chi-square test was performed to 
determine if the increase in the relative number of students who chose the 
correct response to the first exam question following exposure to the curricular 
content was significant. This difference between the pre-exposure and post-
exposure correct responses to the first exam question was significant, X2 (1, 
N=177) = 24.58, p<0.001.  
On the second exam question, 19.64% (n=56) of students who took the 
online survey chose the correct response, which was determined to be an 
insignificant percentage by a chi-square test, X2 (1, N=56) = 0.004, p=0.95. The 
most popular incorrect answer, answer choice C, was chosen by 43% (N=56) of 
students, a significant number as determined by a chi-square test, X2 (1, N=56) = 
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18.29, p<0.001. During the biochemistry exam 49.59% of first-year students 
chose the correct response to the second exam question, which was determined 
to be a significant portion of the respondents by a chi-square test, X2 (1, N=121) 
= 66.20, p<0.001. The most common incorrect answer on the biochemistry exam 
was answer choice C, which was chosen by 32% (N=121) of students, a 
significant number as determined by a chi-square test, X2 (1, N=56) = 11.31, 
p<0.001. A chi-square test was performed to determine if the increase in the 
relative number of correct answers to the second exam question on the 
biochemistry exam, compared to the correct answers on the online survey, was 
significant. The difference between the relative number of correct responses to 
the second exam question on the online survey and biochemistry exam was 
significant, X2 (1, N=177) = 14.28, p<0.001. 
On the pathophysiology exam 62.43% (n=189) of students chose the 
correct answer to the first exam question, which was determined to be a 
significant percentage by a chi square test, X2 (1, N=189) = 212.7, p<0.001. For 
the second exam question, 55.03% (n=189) of students chose the correct 
answer, which was also determined to be significant by a chi square test, X2 (1, 
N=189) = 144.9, p<0.001. Figure 8 illustrates the relative frequency with which 
each answer choice was chosen for the first exam question. The most popular 
incorrect answer to the first exam question given by the second-year students 
was answer choice D, which was chosen by 28% (N=189) of the students. A chi 
square test determined that this incorrect answer represented a significant 
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portion of the student answers, X2 (1, N=189) = 6.667, p<0.01. Figure 9 
illustrates the relative frequency with which each answer choice was chosen for 
the second exam question. The most popular incorrect response given by the 
second-year students to the second exam question was answer choice C, which 
was chosen by 30% (N=189) of students, a significant number as determined by 
a chi-square test, X2 (1, N=189) = 10.95, p<0.001. A chi-square test was 
performed to determine if there was a significant difference between the percent 
of first-year students who correctly answered the first exam question on the 
biochemistry exam exam and students who correctly answered the first exam 
question on the pathophysiology exam. The percentage of first-year students 
who correctly answered the first exam question was significantly higher than the 
pathophysiology students, X2 (1, N=310) = 34.97, p<0.001. This same test was 
repeated for the second exam question, and there was no significant difference 
between the first-year students’ and the pathophysiology students’ correct 
response rates, X2 (1, N=310) = 0.8761, p=0.349. 
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Figure 8. Responses to the First Exam Question. These are relative 
frequencies with which each answer choice was selected on the online survey 
(n=56), the first-year biochemistry exam (n=121) and the second-year 
pathophysiology exam (n=189) for the first exam question, which is described in 
Figure 5. 
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Figure 9. Responses to the Second Exam Question. These are the relative 
frequencies with which each answer choice was selected on the pre-lecture 
online survey (n=56), the first-year biochemistry exam (n=121) and the second-
years pathophysiology exam (n=189) for the second exam question, which is 
described in Figure 6. 
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DISCUSSION 
 
 This study demonstrated that the addition of a transgender medicine unit, 
which is built upon the biological evidence for a rigid gender identity, to the 
medical school curriculum is effective in both educating students about 
transgender medicine and convincing them that gender identity is a rigid 
biological phenomenon and that cross-sex hormone therapy is medically justified. 
Transgender patients face unnecessary barriers to healthcare due in most part to 
a lack of access to knowledgeable physicians. Because few medical schools 
cover transgender medicine in the curriculum many physicians are ill informed, 
and some still believe that gender identity is reversible and that cross-sex 
hormone therapy carries too much risk. These unsupported concerns reduce 
physicians’ willingness to treat transgender patients, and contributes to 
healthcare disparities. The curricular content change in this study aims to 
ameliorate this problem by making the evidence-based argument that cross-sex 
hormone therapy is the best available treatment for transgender patients, with the 
goal of convincing healthcare providers. This is the first study that demonstrates 
that healthcare providers transgender medical knowledge and attitudes can be 
improved with a simple educational intervention. 
We hypothesized that the additional curricular content would change 
students’ attitudes toward transgender medicine. The results of the audience 
response survey demonstrated that prior to the lecture students did not have a 
clear idea of the origin of gender identity. Almost half of first-year students who 
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responded to the audience response survey shared the misconception that 
varying hormone levels determine gender identity. If that were true, then 
transgender identity would be symptomatic of an underlying hormonal condition, 
which it is not. Following exposure to the curricular content, however, a 
significant number of students changed their opinion to reflect that gender 
identity is rooted in the structure of the brain. Overall the results suggest that the 
curricular content was effective in convincing the students that gender identity is 
a rigid biological phenomenon. Additionally the fact that a significant number of 
students changed their answer from “Hormones”, suggests that the content was 
effective in eliminating the misconception that transgender identity is the result of 
an underlying hormonal condition. Despite the misconception held by many 
physicians that gender identity is a malleable social construct, the number of first-
year medical students who thought that gender identity is a social construct was 
not significant. The absence of this misconception, suggests that the idea of 
neonatal sexual neutrality and a reversible gender identity may be instilled during 
medical training, since it was not a common preconceived notion going into 
medical school. Therefore, it would reason that changing medical training to 
include the evidence for rigid gender identity and the safety and effectiveness of 
cross-sex hormone therapy would be an effective means of combating the 
misconception that gender identity is a social construct. 
The first exam question, described in Figure 5, primarily tested students’ 
knowledge of the evidence supporting a biological origin of transgender identity, 
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specifically the gender dimorphic neuroanatomical evidence. Even though the 
majority of the online survey respondents correctly answered this question prior 
to the curricular content, the number of first-year students who selected the 
correct answer choice significantly increased following exposure to the curricular 
content, suggesting that the content was effective in increasing the student’s 
knowledge and understanding of gender identity and transgender identity. 
Because the online survey was elective it is possible that the interested 
respondents were informed on the topic, which could explain why over half of 
them correctly responded prior to the lecture. On the pathophysiology exam 
given to the second-year students the majority of students selected the correct 
response to the first-exam question; however, there was a 31% decrease in 
correct responses compared to the first-year students. The dip in correct 
responses could reflect the durability the information has after being taught. 
There was a full year between when the first-year lecture was given to the cohort 
of second-year students in this study and pathophysiology exam. Additionally, 
28% of pathophysiology students incorrectly chose the response reflecting that 
gender identity is a social construct and the product of postnatal experiences. 
This result, in conjunction with the fact that no significant number of first-year 
students suggested that gender identity was a social construct, supports the 
notion that the ‘gender identity is a social construct’ misconception is perpetuated 
in medical training. It is possible that some students were exposed to this 
misconception between the first-year and second-year lectures. Another possible 
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explanation is that the minority of physician assistant students, none of whom 
received the first-year lecture, may have made up a large portion of the incorrect 
responses. Regardless of why a significant number of pathophysiology students 
thought gender identity was a social construct, they were still only a minority of 
the class. The fact that the majority of students responded correctly suggests that 
the curricular content is effective at increasing knowledge, and that the majority 
of students retain the information over time. 
Once gender identity is recognized as a rigid biological phenomenon 
psychiatric therapies aimed at altering gender identity are not justifiable, leaving 
cross-sex hormone therapy as the best treatment option. The second exam 
question was aimed at testing knowledge, but also assessed whether or not 
students recognized that cross-sex hormone therapy was a viable treatment 
option. In the second exam question, described in Figure 6, students were 
presented with a patient suffering from gender dysphoria and asked to 
recommend a treatment for the patient’s chronic symptoms. Prior to exposure to 
the curricular content the majority of online survey respondents selected answer 
choice C, reflecting a conservative psychiatric treatment focused on the patient’s 
associated mental health concerns, not their gender dysphoria. Following the 
curricular content, however, the majority of both the first-year and the second-
year students chose the correct answer, suggesting that they thought cross-sex 
hormone therapy was the best treatment option. The fact that the majority of 
students who have been exposed to the curricular content were able to correctly 
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answer the question suggests that the content is effective in increasing their 
knowledge of gender identity and convincing them of the legitimacy of cross-sex 
hormone therapy. Despite the fact that the first-year content was primarily 
focused on gender identity, and not cross-sex hormone therapy treatment 
regimens and monitoring regimens, which were covered in the second-year 
content, there was no significant difference between how the first-year and 
second-year students responded, supporting the notion that accepting the 
concept of a rigid biological gender identity increases acceptance of the 
legitimacy of cross-sex hormone therapy.  
Interestingly, a significant number, representing less than one-third of both 
the first-year and second-year students incorrectly chose the answer choice C on 
the second exam question, which reflected that they thought that a psychiatric 
approach aimed at treating the associated mental health concerns was the best 
treatment option. These results could suggest that a minority of students remain 
unconvinced by the evidence presented that cross-sex hormone therapy is 
legitimate, and would rather manage the symptoms of depression and anxiety 
associated with gender dysphoria, than the gender dysphoria itself. Another 
possible explanation is that this question was simply more difficult than the first 
exam question. To find the correct answer one must recognize that gender 
identity is rigid and that other mental health concerns are ameliorated by 
treatment of body dysmorphia in order to come to the conclusion that cross-sex 
hormone therapy would be the best treatment, as apposed to the first exam 
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question which simply required recall of the association between transgender 
and gender dimorphic neuroanatomical structures. 
A major limitation to this study is that it was conducted at one medical 
school. Boston University is located in a particularly socially liberal and LGBT 
friendly part of the nation. It is possible that the socio-political climate influenced 
the results. A liberal student body may be more receptive to such a controversial 
topic than a more conservative group. However, the information presented in the 
curriculum relies heavily on biological evidence, which should circumvent some 
of the effects of political opinion. Additionally, young medical students may be 
less likely to scrutinize what they are taught and more likely to accept the 
conclusions presented by a professor. It is possible that if the same information 
was presented to groups of medical residents, newly practicing physicians, and 
long practicing physicians that not all groups would be as receptive to the 
information. Another limitation was the low number of online survey respondents, 
which may represent a more interested group that may not necessarily be 
completely representative of the entire class. The low number of lecture 
attendees compared to the number of test-takers is another limitation. There 
were 43 students who responded to the first-year audience response questions, 
but 121 students who took the exam. It is possible that the remaining 64% 
students who did not respond or attend lecture were not as convinced regarding 
the etiology of gender identity. Additionally, only 70 to 100 students attended the 
pathophysiology lecture, but 189 students took the exam. While both the first-
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year and second-year lectures were recorded and posted online, there is no way 
to know if the absent students actually watched the lecture prior to the exam, 
which may have skewed the results.  
The study’s limitations do, however, provide new avenues for research. 
Due to the nature of the curricular content it would be possible to add the exact 
same material to medical school curricula across the country to determine if geo-
political climates do indeed indeed have an influence on how effective the 
curricular content is in creating informed physicians who are willing to treat 
transgender patients. Additionally the content could be adapted to be presented 
to medical residents and long practicing physicians to assess if the content can 
universally inform and convince healthcare providers of the merits of treating 
transgender patients with hormones. Further research should be done to assess 
why this curricular content is effective. Isolating the most convincing parts of the 
argument would assist in the adaptation of the curriculum to other medical 
professionals. Another possible follow up to this research would be investigating 
the misconception that gender identity is a social construct, and specifically why 
only the pathophysiology students had a significant number of people who 
adhered to the misconception. 
Overall the curricular content change increased medical students’ 
knowledge of transgender medicine and made them more receptive to cross-sex 
hormone therapy as a legitimate, effective, and safe treatment option for 
transgender patients. In 2013 Safer & Pearce demonstrated that the same 
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curricular content change presented in this study increased medical students’ 
comfort with treating transgender patients, and reduced students’ anticipated 
apprehension towards providing cross-sex hormone therapy. Together our 
findings suggest that this curricular content change is effective in training 
physicians who are knowledgeable and willing to provide care for transgender 
patients, and that making transgender medicine a part of the standard medical 
school curriculum could provide a possible means for addressing and eliminating 
the barriers to safe transgender healthcare. However, focusing solely on medical 
school education can only bring about change slowly, as the ratio of current 
physicians to current medical students is large. In order to completely eliminate 
the difficulties accessing care brought about by the lack of knowledgeable and 
willing transgender care providers, the curriculum content must be adapted to 
reach a multitude of healthcare providers with varying years of experience 
practicing medicine. 
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